Impact BioMedical, Inc. (IBO) — Cash Flow Quality Index

Latest as of September 2024: -0.30x

Impact BioMedical, Inc. (IBO) has a Cash Flow Quality Index of -0.30x as of September 2024. Operating cash flow of $-1.74 Million is below net income of $5.74 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Impact BioMedical, Inc. cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.30x

Operating CF / Net Income

Operating Cash Flow

$-1.74 Million

USD

Net Income

$5.74 Million

USD

Data as of

Sep 2024

Most recent filing

Annual Cash Flow Quality Index for Impact BioMedical, Inc. (None–None)

Year-by-year earnings quality comparison for Impact BioMedical, Inc..

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.